Company Filing History:
Years Active: 1995
Title: Russell B. Whitman: Innovator in Angiogenic Peptides
Introduction
Russell B. Whitman is a notable inventor based in Dix Hills, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of angiogenic peptides. His work focuses on the therapeutic potential of these peptides in promoting wound healing and tissue repair.
Latest Patents
Whitman holds a patent for "Angiogenic Peptides." This invention relates to peptides and peptide derivatives associated with platelet factor 4, which exhibit angiogenic activity. The patent outlines pharmaceutical compositions that include these peptides and methods for promoting angiogenesis. The discovery highlights an octapeptide derived from platelet factor 4 and seven related peptides capable of inducing an angiogenic response in vivo. This response is measured through neovascularization in rabbit corneal implant assays and capillary endothelial cell chemoattraction. The angiogenic peptides are particularly useful in promoting wound healing, including incisional healing, bone repair, burn healing, and post-infarction repair in myocardial injury.
Career Highlights
Whitman is affiliated with Curative Technologies, Inc., where he continues to advance his research in angiogenic peptides. His innovative work has the potential to significantly impact the medical field, especially for patients suffering from vascular insufficiency, such as those with diabetes.
Collaborations
Some of his notable coworkers include Robert Wohl and Ronald G. Duff. Their collaborative efforts contribute to the ongoing research and development of therapeutic applications for angiogenic peptides.
Conclusion
Russell B. Whitman's contributions to the field of biotechnology through his patent on angiogenic peptides demonstrate his commitment to advancing medical science. His work holds promise for improving healing processes and enhancing the quality of life for patients with various medical conditions.